source
- Novo Nordisk secures biotech partner for Parkinson's cell therapy as GSK signs hepatitis B drug deal in ChinaNovo Nordisk has found a biotech partner to advance its early‑stage Parkinson's disease cell therapy, giving the program a new development home. GSK disclosed a commercial agreement to sell its he…
- Providers and insurers vie to influence upcoming No Surprises Act arbitration ruleThe federal government is preparing to release a final rule that will reshape the arbitration process under the No Surprises Act. Health care providers and insurers are both scrambling to have thei…